Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
02/1994
02/23/1994CN1082533A A process for making 1-cyclopentylalkyl amines useful for the synthesis of sweeteners
02/22/1994US5288851 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
02/22/1994US5288707 Thrombin inhibitors
02/22/1994US5288514 Linking a protected 2-aminobenzophenone to a substrate; deprotecting and reacting with an amino acid; cyclization; removal from substrate; screening
02/17/1994WO1994003597A1 Peptides inhibiting ras protein activity, preparation and use thereof
02/17/1994WO1994003494A1 Conformationally restricted mimetics of reverse turns and peptides containing the same
02/17/1994WO1994003485A1 Peptide lung surfactants and therapeutic combinations
02/17/1994WO1994003484A1 Synthetic peptide lung surfactants having covalently bonded antioxidants
02/17/1994WO1994003483A1 Endothelin receptor-binding compounds
02/17/1994WO1994003482A1 Glycyl-hystidyle-lysine (ghl) derivatives
02/17/1994WO1994003481A1 Diamino acid derivatives as antihypertensives
02/17/1994WO1994003480A1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents
02/17/1994WO1994003479A1 Thrombin receptor antagonists
02/17/1994WO1994003469A1 New derivatives of neuraminic acid
02/17/1994WO1994003468A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
02/17/1994WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof
02/17/1994CA2141785A1 Diamino acid derivatives as antihypertensives
02/17/1994CA2141581A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
02/17/1994CA2141447A1 Conformationally restricted mimetics of reverse turns and peptides containing the same
02/17/1994CA2141061A1 Peptides inhibiting ras protein activity, preparation and use thereof
02/17/1994CA2139854A1 Peptidyl 4-amino-2, 2-difluoro-3-oxo-1, 6-hexanedioic acid derivatives as antiinflammatory agents
02/16/1994EP0583074A2 Angiotensin converting enzyme inhibitor and method for preparing same
02/16/1994EP0582631A1 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
02/16/1994EP0343241B1 A method of inhibiting platelet dependent arterial thrombosis
02/16/1994CN1082035A Inhibitors of hiv protease useful for the treatment of aids
02/16/1994CN1082027A 异羟肟酸衍生物 Hydroxamic acid derivatives
02/15/1994US5286904 Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
02/15/1994US5286715 New adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use
02/15/1994US5286509 L-aspartyl-D-α-aminoalkanoyl-(S)-N-alpha-alkylbenzyl amides useful as artificial sweeteners
02/15/1994CA1327094C Method for producing .alpha.-aspartylphenylalanine derivatives
02/09/1994EP0582351A1 Process for the crystallisation of aspartame
02/09/1994EP0582303A1 Method for the production of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride
02/09/1994EP0582243A2 HCV peptide antigens and a method of testing for the hepatitis C virus (HCV)
02/09/1994EP0581899A1 Improved process for the preparation of 1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n- (1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
02/08/1994US5284849 Renin inhibitors
02/08/1994US5284841 Benzo-fused lactams promote release of growth hormone
02/08/1994US5284829 Synthetic tetrapeptides for the prevention of schistosome parasite infection
02/08/1994US5284828 Peptide compound and its preparation
02/08/1994CA2103536A1 Peptides capable of inhibiting the activity of hiv protease, their preparation and their use
02/08/1994CA2103533A1 Hcv peptide antigens and method of determining hcv
02/06/1994CA2101870A1 Method for the production of .alpha.-l-aspartyl-l- phenylalanine methyl ester hydrochloride
02/03/1994WO1994002445A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
02/03/1994WO1994002441A1 A process for making 1-cyclopentylalkyl amines useful for the synthesis of sweeteners
02/03/1994WO1994002162A1 Peptide medicaments for treating disease
02/03/1994CA2140931A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression
02/03/1994CA2140033A1 Peptide medicaments for treating disease
02/02/1994EP0581032A1 Method for production of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride
02/01/1994US5283357 Separation method of α-l-aspartyl-l-phenylalanine methyl ester
02/01/1994US5283241 Animal growth regulators
02/01/1994CA1326738C Method for producing .alpha.-l-aspartyl-l-phenylalanine derivatives
02/01/1994CA1326737C Phosphinic acid derivatives
01/1994
01/29/1994CA2101350A1 Peptides derived from trifluoromethylketones, a process for their preparation and pharmaceutical compositions containing them
01/26/1994EP0580008A2 Phenylimidazolidine Derivatives, their preparation and use
01/26/1994EP0579758A1 Parathyroid hormone receptor and dna encoding same
01/26/1994EP0579661A1 Branched peptides in assays for antibodies
01/26/1994EP0423301B1 Synthetic peptides of the conjugate of ubiquitine and histone h2a
01/25/1994US5281717 Pharmaceuticals
01/25/1994US5281635 Precious metal composition
01/20/1994WO1994001456A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention
01/20/1994WO1994001455A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors
01/20/1994WO1994001451A2 Method for modification of recombinant polypeptides
01/20/1994WO1994001421A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists
01/20/1994WO1994001126A1 Compounds for inhibition of proteolysis
01/20/1994DE4220566A1 Inhibitoren retroviraler Proteasen Inhibitors of retroviral proteases
01/20/1994CA2140002A1 A chemical method for selective modification of the n- and/or c-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof
01/20/1994CA2139429A1 Oligopeptide derivatives and their use in secondary cataract prevention
01/20/1994CA2139421A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors
01/20/1994CA2139417A1 Benzothiazepine and benzoxazepine derivatives
01/20/1994CA2120954A1 Allergenic proteins and peptides from japanese cedar pollen
01/19/1994EP0579277A1 Imidazole derivatives, their preparation and their use as synthetic intermediates
01/19/1994EP0578745A1 Phosphorus containing compounds as inhibitors of retroviruses
01/18/1994US5279946 Process for the preparation of N-benzyloxycarbonyl-alpha-L-aspartyl-L-phenylalanine methyl ester
01/18/1994CA1326326C Platelet-aggregation inhibitors
01/12/1994EP0578535A1 New peptide derivates active in the process of cell adhesion, a method to prepare them end pharmaceutical compositions containing them
01/12/1994EP0577775A1 Anti-thrombotic peptides and pseudopeptides
01/12/1994EP0577690A1 Organosulphur compounds useful for the treatment of glaucoma
01/12/1994EP0577682A1 Small peptidic compounds useful for the treatment of glaucoma
01/12/1994EP0500629B1 Edulcorant derived from l-aspartic or l-glutamic acid and its preparation process
01/11/1994US5278316 Indoles
01/11/1994US5278148 Hypotensive agents
01/11/1994US5278061 Epoxy-activated crosslinked dextran adsorbers
01/11/1994US5277893 Direct radiolabeling of substrates containing monosulfides or disulfide bonds with radionuclides
01/11/1994US5277892 Administering a mixture of a lectin and a linked imaging ion
01/11/1994CA1326108C Cck antagonists
01/11/1994CA1326107C Heterocyclic ketones
01/11/1994CA1326029C 4-thiazolidine-carboxylic acid derivative, its preparation and pharmaceutical compositions containing it
01/06/1994WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof
01/06/1994WO1994000509A1 Oxazolone derived materials
01/06/1994WO1994000492A1 Angiotensin iv peptides and receptor
01/06/1994WO1994000489A2 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses
01/06/1994WO1994000485A1 Multimeric forms of human rhinovirus receptor protein
01/06/1994WO1994000461A1 Inhibitors of retroviral proteases
01/06/1994WO1994000421A1 Bicyclooctane and bicycloheptane derivatives
01/06/1994WO1994000419A1 Inhibitors of farnesyl protein transferase
01/06/1994WO1994000156A1 Polymer-bound paclitaxel derivatives
01/06/1994WO1994000028A2 L-ASPARTYL-D-α-AMINOALKANOYL-(S)-N-α-ALKYLBENZYL AMIDES USEFUL AS ARTIFICIAL SWEETENERS
01/06/1994CA2139350A1 Oxazolone derived materials
01/06/1994CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof
01/06/1994CA2139105A1 Angiotensin iv peptides and receptor
01/06/1994CA2138248A1 L-aspartyl-d-ó-aminoalkanoyl-(s)-n-ó-alkylbenzyl amides useful as artificial sweeteners